Phase I Study of Immunotherapy of Malignant Melanoma by Direct Gene Transfer

Evan M. Hersh; Emmanuel Akporiaye; David Harris; Alison T. Stopeck; Evan C. Unger; James A. Warneke; Steven A. Kradjian

doi:10.1089/hum.1994.5.11-1371

Phase I Study of Immunotherapy of Malignant Melanoma by Direct Gene Transfer

Evan M. Hersh, Emmanuel Akporiaye, David Harris, Alison T. Stopeck, Evan C. Unger, James A. Warneke, Steven A. Kradjian

Cancer Center

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Original language	English (US)
Pages (from-to)	1371-1384
Number of pages	14
Journal	Human Gene Therapy
Volume	5
Issue number	11
DOIs	https://doi.org/10.1089/hum.1994.5.11-1371
State	Published - Nov 1 1994

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Genetics

Access to Document

10.1089/hum.1994.5.11-1371

Cite this

@article{de29071685f94fb08388713c37961621,

title = "Phase I Study of Immunotherapy of Malignant Melanoma by Direct Gene Transfer",

author = "Hersh, {Evan M.} and Emmanuel Akporiaye and David Harris and Stopeck, {Alison T.} and Unger, {Evan C.} and Warneke, {James A.} and Kradjian, {Steven A.}",

year = "1994",

month = nov,

day = "1",

doi = "10.1089/hum.1994.5.11-1371",

language = "English (US)",

volume = "5",

pages = "1371--1384",

journal = "Human Gene Therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "11",

}

TY - JOUR

T1 - Phase I Study of Immunotherapy of Malignant Melanoma by Direct Gene Transfer

AU - Hersh, Evan M.

AU - Akporiaye, Emmanuel

AU - Harris, David

AU - Stopeck, Alison T.

AU - Unger, Evan C.

AU - Warneke, James A.

AU - Kradjian, Steven A.

PY - 1994/11/1

Y1 - 1994/11/1

UR - http://www.scopus.com/inward/record.url?scp=0028560462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028560462&partnerID=8YFLogxK

U2 - 10.1089/hum.1994.5.11-1371

DO - 10.1089/hum.1994.5.11-1371

M3 - Article

C2 - 7893808

AN - SCOPUS:0028560462

VL - 5

SP - 1371

EP - 1384

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 11

ER -